Chiba, Japan

Yasumi Uchida


Average Co-Inventor Count = 10.3

ph-index = 3

Forward Citations = 55(Granted Patents)


Company Filing History:


Years Active: 1985-1994

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Yasumi Uchida

Introduction

Yasumi Uchida is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of pharmacology, particularly through his innovative aminopyridine compounds. With a total of four patents to his name, Uchida's work has the potential to impact the treatment of circulatory diseases.

Latest Patents

Uchida's latest patents include aminopyridine compounds that are represented by specific chemical formulas. These compounds are designed to exhibit excellent pharmacological effects while minimizing side effects. The first patent describes an aminopyridine compound where various groups and substituents are defined, contributing to its effectiveness as a drug for circulatory diseases. The second patent also focuses on aminopyridine compounds with similar structural characteristics, emphasizing their potential in medical applications.

Career Highlights

Throughout his career, Yasumi Uchida has worked with prominent companies in the pharmaceutical industry. He has been associated with the Green Cross Corporation and Chugai Seiyaku Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development.

Collaborations

Uchida has collaborated with notable colleagues in his field, including Tadahiro Takemoto and Masahiro Eda. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Yasumi Uchida's contributions to the field of pharmacology through his aminopyridine compounds highlight his innovative spirit and dedication to improving medical treatments. His work continues to pave the way for advancements in drug development for circulatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…